The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · IEX Real-Time Price · USD
20.71
-0.71 (-3.31%)
Apr 24, 2024, 4:00 PM EDT - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $621.56 million as of April 24, 2024. Its market cap has increased by 57.68% in one year.
Market Cap
621.56M
Enterprise Value
945.13M
1-Year Change
57.68%
Ranking
Category
Stock Price
$20.71
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.50M to $621.56M, an increase of 47.12%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 642.90M | 2.73% |
| Apr 22, 2024 | 625.80M | 2.71% |
| Apr 19, 2024 | 609.30M | 2.06% |
| Apr 18, 2024 | 597.00M | -0.60% |
| Apr 17, 2024 | 600.60M | - |
| Apr 16, 2024 | 600.60M | 0.50% |
| Apr 15, 2024 | 597.60M | -1.43% |
| Apr 12, 2024 | 606.30M | -0.74% |
| Apr 11, 2024 | 610.80M | 0.74% |
| Apr 10, 2024 | 606.30M | -1.80% |
| Apr 9, 2024 | 617.40M | -0.29% |
| Apr 8, 2024 | 619.20M | -0.43% |
| Apr 5, 2024 | 621.90M | 2.98% |
| Apr 4, 2024 | 603.90M | -0.98% |
| Apr 3, 2024 | 609.90M | 1.30% |
| Apr 2, 2024 | 602.10M | -0.25% |
| Apr 1, 2024 | 603.60M | 2.46% |
| Mar 28, 2024 | 589.10M | -1.06% |
| Mar 27, 2024 | 595.40M | 1.74% |
| Mar 26, 2024 | 585.20M | -1.17% |
| Mar 25, 2024 | 592.10M | 0.15% |
| Mar 22, 2024 | 591.20M | -3.07% |
| Mar 21, 2024 | 609.90M | 1.55% |
| Mar 20, 2024 | 600.60M | 1.44% |
| Mar 19, 2024 | 592.10M | 4.11% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 706.88B |
| Novo Nordisk | 565.69B |
| UnitedHealth Group | 449.55B |
| Johnson & Johnson | 362.21B |
| Merck & Co. | 321.70B |
| AbbVie | 301.19B |
| AstraZeneca | 220.03B |
| Thermo Fisher | 219.59B |